Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer☆

ESMO Open · Elsevier

Аннотация

Publication date: November 2026 Source: ESMO Open, Volume 11, Issue 11 Author(s): Y.H. Park, H.S. Rugo, N. Chittoria, R. Sacks, J. Chiu, C. Murphy, O. Ayodele, G.M. Kim, K.S. Lee, W. Xu, R. Joshi, A. Kwong, M. Dong, Y. Zhang, R. Rong, E. Lopez Rodrigo, N. Rainey, S. Adams

Читать у издателя →

Похожие статьи